Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: unbiased (1), impartial (11), pale (37)

PLANETS texture modified recipe book

Description: A texture modified recipe book for patients with cancer of the oesophagus or stomach A texture modified recipe boo
Url: /Media/UHS-website-2019/Docs/Services/planets-texture-modified-recipe-book.pdf

Trastuzumab (21 day-Maintenance)

Description: Chemotherapy Protocol BREAST CANCER TRASTUZUMAB (21 day- Maintenance) Regimen • Breast Cancer – Trastuzumab (21 day-Maintenance) Indication • A
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-21-day-Maintenance.pdf

Trastuzumab (21 day-Load)

Description: Chemotherapy Protocol BREAST CANCER TRASTUZUMAB (21 day-Load) Regimen • Breast Cancer – Trastuzumab (21 day-Load) Indication • Adjuvant treatment of breast cancer ove
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Trastuzumab-21-day-Load.pdf

Trastuzumab Main

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER TRASTUZUMAB (21 day-Maintenance) Regimen • GI (upper) – Trastuzumab (21 day-Maintenance) Indication • Trastuzuma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/TrastuzumabMainVer1.2.pdf

Cytarabine1500

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (1500mg/m2) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (1500mg/m2) In
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine1500.pdf

Gemcitabine

Description: Chemotherapy Protocol PANCREATIC CANCER GEMCITABINE Regimen  Pancreatic Cancer – Gemcitabine Indication  Adjuvant treatment of pancreatic cancer  First line treatmen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Gemcitabine.pdf

Gemcitabine

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) GEMCITABINE Regimen NSCLC - Gemcitabine Indication Second line therapy of stage III or IV NSCLC WHO Performance
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Gemcitabinever12.pdf

Gemcitabine RT ver1

Description: Chemotherapy Protocol BLADDER CANCER GEMCITABINE RT Regimen Bladder – Gemcitabine RT Indication The treatment of muscle invasive bladder cancer WHO Performance status
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-RT-ver1.pdf

Gemcitabine (21day) ver1.1

Description: Chemotherapy Protocol BLADDER GEMCITABINE (21 day) Regimen Bladder-Gemcitabine Indication Locally advanced or metastatic urothelial cancer in patients unsuitable for
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-21day-ver1.1.pdf

Rituximab (weekly)

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB (weekly) Regimen Lymphoma – Rituximab (weekly) Indication CD20 positive indolent non Hodgkin’s lymphoma. Toxicity
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-weekly.pdf

71 to 80 of 265

Previous … 6 7 8 9 10 … Next